Seguir
Charles Day
Charles Day
Graduate Student, Vanderbilt University
Dirección de correo verificada de vanderbilt.edu
Título
Citado por
Citado por
Año
Simplified equation to extract diffusion coefficients from confocal FRAP data
M Kang, CA Day, AK Kenworthy, E DiBenedetto
Traffic 13 (12), 1589-1600, 2012
2642012
Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanism
RP Mason, MF Walter, CA Day, RF Jacob
Journal of biological chemistry 281 (14), 9337-9345, 2006
2142006
Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions
RP Mason, MF Walter, CA Day, RF Jacob
The American journal of cardiology 96 (5), 11-23, 2005
1982005
Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction
RP Mason, R Kubant, G Heeba, RF Jacob, CA Day, YS Medlin, ...
Pharmaceutical research 25, 1798-1806, 2008
1692008
Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs
MF Walter, RF Jacob, CA Day, R Dahlborg, Y Weng, RP Mason
Atherosclerosis 177 (2), 235-243, 2004
1532004
Tracking microdomain dynamics in cell membranes
CA Day, AK Kenworthy
Biochimica et Biophysica Acta (BBA)-Biomembranes 1788 (1), 245-253, 2009
1482009
A generalization of theory for two-dimensional fluorescence recovery after photobleaching applicable to confocal laser scanning microscopes
M Kang, CA Day, K Drake, AK Kenworthy, E DiBenedetto
Biophysical journal 97 (5), 1501-1511, 2009
1162009
Analysis of protein and lipid dynamics using confocal fluorescence recovery after photobleaching (FRAP)
CA Day, LJ Kraft, M Kang, AK Kenworthy
Current protocols in cytometry 62 (1), 2.19. 1-2.19. 29, 2012
1092012
Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicity
RP Mason, MF Walter, HP McNulty, SF Lockwood, J Byun, CA Day, ...
Journal of Cardiovascular Pharmacology 47, S7-S14, 2006
1042006
Intermolecular differences for HMG-CoA reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions
RP Mason, MF Walter, CA Day, RF Jacob
Am. J Cardiol 96 (5A), 11F-23F, 2005
992005
Chromosome missegregation during anaphase triggers p53 cell cycle arrest through histone H3. 3 Ser31 phosphorylation
EH Hinchcliffe, CA Day, KB Karanjeet, S Fadness, A Langfald, ...
Nature cell biology 18 (6), 668-675, 2016
922016
Functions of cholera toxin B-subunit as a raft cross-linker
CA Day, AK Kenworthy
Essays in biochemistry 57, 135-145, 2015
792015
A quantitative approach to analyze binding diffusion kinetics by confocal FRAP
M Kang, CA Day, E DiBenedetto, AK Kenworthy
Biophysical journal 99 (9), 2737-2747, 2010
782010
Mechanisms underlying the confined diffusion of cholera toxin B-subunit in intact cell membranes
CA Day, AK Kenworthy
PloS one 7 (4), e34923, 2012
632012
Microtubule Motors Power Plasma Membrane Tubulation in Clathrin‐Independent Endocytosis
CA Day, NW Baetz, CA Copeland, LJ Kraft, B Han, A Tiwari, KR Drake, ...
Traffic 16 (6), 572-590, 2015
622015
Lysosomal degradation ensures accurate chromosomal segregation to prevent chromosomal instability
E Almacellas, J Pelletier, C Day, S Ambrosio, A Tauler, C Mauvezin
Autophagy 17 (3), 796-813, 2021
352021
A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAids
RP Mason, MF Walter, CA Day, RF Jacob
Inflammation in the Pathogenesis of Chronic Diseases: The COX-2 Controversy …, 2007
342007
Topologically diverse human membrane proteins partition to liquid-disordered domains in phase-separated lipid vesicles
JP Schlebach, PJ Barrett, CA Day, JH Kim, AK Kenworthy, CR Sanders
Biochemistry 55 (7), 985-988, 2016
232016
Engineered disulfide bond greatly increases specific activity of recombinant murine interferon-β
C DAY, B SCHWARTZ, BL Li, S PESTKA
Journal of interferon research 12 (2), 139-143, 1992
211992
Increased susceptibility of Pseudomonas aeruginosa to ciprofloxacin in the presence of vancomycin
CA Day, ML Marceau-Day, DF Day
Antimicrobial agents and chemotherapy 37 (11), 2506-2508, 1993
191993
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20